Pandemic H1N1 infl uenza A: treatment and prevention for 2010 infl uenza season

Abstract

Novel H1N1 infl uenza is a new infl uenza stain that has not been seen before. Most cases are mild and self-limiting. However, there are individuals at high risk of complicated illness and there are cases of rapidly progressive disease in previously healthy individuals. Depending on the severity of the H1N1 influenza infection, antiviral medication may be indicated, possibly with antibiotics or other required therapy. Influenza vaccination is the most important tool in the prevention of influenza. Pneumococcal vaccination should be encouraged for those individuals at increased risk of pneumococcal infection. Antiviral postexposure prophylaxis may be considered for high-risk individuals with close contact of a confi rmed or suspected case of pandemic H1N1 influenza. However, an alternative of early recognition of influenza and rapid treatment may be suitable depending on the specific situation.